VG Life Sciences Inc. (VGLS) financial statements (2021 and earlier)

Company profile

Business Address 121 GRAY AVENUE, SUITE 200
SANTA BARBARA, CA 93101
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments0
Cash and cash equivalents0
Other undisclosed current assets0
Total current assets:0
Noncurrent Assets
Intangible assets, net (including goodwill)1
Intangible assets, net (excluding goodwill)1
Total noncurrent assets:1
TOTAL ASSETS:1
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1
Accounts payable1
Accrued liabilities0
Interest and dividends payable0
Debt2
Derivative instruments and hedges, liabilities1
Due to related parties2
Other undisclosed current liabilities0
Total current liabilities:6
Noncurrent Liabilities
Total liabilities:6
Stockholders' equity
Stockholders' equity attributable to parent, including:(5)
Preferred stock0
Common stock0
Additional paid in capital101
Accumulated deficit(106)
Other undisclosed stockholders' equity attributable to parent1
Stockholders' equity attributable to noncontrolling interest1
Total stockholders' equity:(4)
Other undisclosed liabilities and equity(1)
TOTAL LIABILITIES AND EQUITY:1

Income statement (P&L) ($ in millions)

12/31/2014
Gross profit:(2)
Operating expenses(2)
Operating loss:(4)
Nonoperating expense
(Other Nonoperating expense)
(2)
Interest and debt expense(3)
Loss from continuing operations before income taxes:(9)
Income tax expense(2)
Loss before gain (loss) on sale of properties:(11)
Other undisclosed net income5
Net loss:(6)
Net income attributable to noncontrolling interest0
Net loss available to common stockholders, diluted:(6)

Comprehensive Income ($ in millions)

12/31/2014
Net loss:(6)
Comprehensive loss:(6)
Comprehensive income, net of tax, attributable to noncontrolling interest0
Comprehensive loss, net of tax, attributable to parent:(6)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: